ZEOX insider trading
OTC Markets OTCQB HealthcareZeo ScientifiX, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Zeo ScientifiX, Inc.
Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, osteoarthritis,and traumatic brain injury. The company also provides Patient Pure X, an autologous biologic, that helps reduce inflammation and promote tissue healing and regeneration. In addition, it develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROWX, ZEO HAIR GROW, and ZEO GROW BOOST, a serum comprised of hair growth stimulants for follicle stimulation. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is based in Davie, Florida.
Company website: www.zeoscientifix.com
ZEOX insider activity at a glance
FilingIQ has scored 55 insider transactions for ZEOX since Apr 1, 2024. The most recent filing in our index is dated Jun 10, 2026.
Across the full history, 41 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ZEOX insider trades is 34.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ZEOX?
- FilingIQ tracks 55 Form 4 insider transactions for ZEOX (Zeo ScientifiX, Inc.), covering filings from Apr 1, 2024 onwards. 7 of those were filed in the last 90 days.
- Are ZEOX insiders net buyers or net sellers?
- Across the full Form 4 history for ZEOX, 41 transactions (75%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ZEOX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ZEOX in?
- Zeo ScientifiX, Inc. (ZEOX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $17.34M.
Methodology & sources
Every ZEOX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.